NO950134L - Formuleringer for oralt administrerte farmasöytiske midler - Google Patents

Formuleringer for oralt administrerte farmasöytiske midler

Info

Publication number
NO950134L
NO950134L NO950134A NO950134A NO950134L NO 950134 L NO950134 L NO 950134L NO 950134 A NO950134 A NO 950134A NO 950134 A NO950134 A NO 950134A NO 950134 L NO950134 L NO 950134L
Authority
NO
Norway
Prior art keywords
formulations
orally administered
pharmaceutical agents
administered pharmaceutical
compound
Prior art date
Application number
NO950134A
Other languages
English (en)
Norwegian (no)
Other versions
NO950134D0 (no
Inventor
Stephanie Ann Sweetana
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO950134D0 publication Critical patent/NO950134D0/no
Publication of NO950134L publication Critical patent/NO950134L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO950134A 1994-03-01 1995-01-13 Formuleringer for oralt administrerte farmasöytiske midler NO950134L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20342494A 1994-03-01 1994-03-01

Publications (2)

Publication Number Publication Date
NO950134D0 NO950134D0 (no) 1995-01-13
NO950134L true NO950134L (no) 1995-09-04

Family

ID=22753951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950134A NO950134L (no) 1994-03-01 1995-01-13 Formuleringer for oralt administrerte farmasöytiske midler

Country Status (15)

Country Link
EP (1) EP0670166A3 (de)
JP (1) JPH0840936A (de)
KR (1) KR950031039A (de)
CN (1) CN1114588A (de)
AU (1) AU1354495A (de)
BR (1) BR9500754A (de)
CA (1) CA2138607A1 (de)
CZ (1) CZ51995A3 (de)
HU (1) HUT75252A (de)
IL (1) IL112745A0 (de)
NO (1) NO950134L (de)
NZ (1) NZ270145A (de)
PE (1) PE10396A1 (de)
PL (1) PL307469A1 (de)
ZA (1) ZA95936B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
JP2002534371A (ja) * 1999-01-06 2002-10-15 コリア リサーチ インスティテュート オブ ケミカル テクノロジー 水不溶性薬物を含む医薬的活性成分の製造方法及びそれを含む経口投与用医薬組成物
KR100435141B1 (ko) * 2000-12-28 2004-06-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR100455216B1 (ko) * 2001-06-27 2004-11-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
KR100425755B1 (ko) * 2001-08-27 2004-04-03 주식회사 원진신약 이트라코나졸을 함유하는 조성물 및 그 제조방법
US20050058670A1 (en) * 2003-09-09 2005-03-17 Jong-Soo Woo Oral itraconazole composition which is not affected by ingested food and process for preparing same
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
WO2010059727A1 (en) * 2008-11-20 2010-05-27 Teikoku Pharma Usa, Inc. Pyrazalone derivative formulations
US20110070293A1 (en) 2009-09-23 2011-03-24 Javeri Indu Methods for the Preparation of Liposomes Comprising Docetaxel
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
WO2018102345A1 (en) * 2016-11-30 2018-06-07 Agrobiologics Llc Use of the antifungal aureobasidin a in agriculture
WO2020236802A1 (en) * 2019-05-20 2020-11-26 Poviva Corp. Compositions comprising biologically active agents and bile salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPH04305534A (ja) * 1991-04-02 1992-10-28 Takara Shuzo Co Ltd オーレオバシジン類製剤
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
JPH0672890A (ja) * 1992-06-26 1994-03-15 Nippon Kayaku Co Ltd オーレオバシジン類の乳化製剤

Also Published As

Publication number Publication date
HU9500618D0 (en) 1995-04-28
KR950031039A (ko) 1995-12-18
BR9500754A (pt) 1995-10-24
EP0670166A2 (de) 1995-09-06
PL307469A1 (en) 1995-09-04
PE10396A1 (es) 1996-04-11
NO950134D0 (no) 1995-01-13
CN1114588A (zh) 1996-01-10
AU1354495A (en) 1995-09-07
HUT75252A (en) 1997-05-28
JPH0840936A (ja) 1996-02-13
ZA95936B (en) 1995-10-09
NZ270145A (en) 1996-08-27
CZ51995A3 (en) 1995-10-18
CA2138607A1 (en) 1995-09-02
EP0670166A3 (de) 1996-06-12
IL112745A0 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
NO20005431D0 (no) Gelérbare farmasøytiske preparater
AR018829A1 (es) Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
BG106439A (en) Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
DK1189620T3 (da) Formulering indeholdende testosteronundecanoat og amerikansk olie
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
NO961136L (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
CY1112510T1 (el) Φαρμακευτικο παρασκευασμα υπο τη μορφη παστας το οποιο περιεχει ενα ασταθες στα οξεα δραστικο συστατικο
EP0287341B1 (de) Rektal absorbierbare Form von L-Dopa
CO5560580A2 (es) Formulaciones de sucralosa para disumular sabores desagradables
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
CA2215327A1 (en) Formulations for lipophilic compounds
ES2238393T3 (es) Composiciones farmaceuticas conteniendo mupirocina en forma amorfa.
CA2231342A1 (fr) Composition pharmaceutique pour administration par voie orale
ES2149990T3 (es) Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes.
US4888343A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
AR013967A1 (es) UNA FORMULACION MEDICAMENTOSA PARA LA ADMINISTRACION ORAL DE PELLET DE DIFUSION CONTROLADA QUE TIENE LIBERACION CONTROLADA DE UN COMPUESTO ACTIVO QUE ES SELECCIONADO DEL ACIDO 1-CICLOPROPIL-7- [(S,S)-2,8-DIAZABICICLO [4.3.0] NON-8-IL ]-6-FLuOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLON CARBOXILICO O SALE
TNSN97134A1 (fr) Comprime de maleate de trimebutine pellicule
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
HUP9901887A2 (hu) HIV-proteáz inhibitort és vízoldékony E-vitamin származékokat tartalmazó gyógyászati készítmények
NO20002590L (no) Formuleringer omfattende oppløst paroxetin